CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 24 enrolled
Drug / intervention
ADIPOSE TISSUE EXTRACT +1 morebiological
Likely dose
Not stated in record
Key inclusion· 1
  • ✓Patients undergoing split-thickness skin graft donor site procedures
Key exclusion· 5
  • ✕Immunosuppressive states
  • ✕Terminal renal insufficiency
  • ✕Pregnancy
  • ✕Coagulation disorders

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02799290
NCT02799290Phase 2Completed
CompareCT.gov

The Effect of Adipose Tissue Extract and Platelet-rich Plasma on Split-thickness Donor Site Wound Healing. A Comparative Study

Tampere University·interventional·Posted Jun 14, 2016·Updated Jan 7, 2021

In Brief

A Phase 2 clinical trial evaluating ADIPOSE TISSUE EXTRACT and PLATELET-RICH PLASMA GEL for Wound Healing Disturbance of. Completed, enrolled 24 participants across 1 site.

Detailed Summary

Adipose Tissue Extract (ATE) has been found to be an autologous source of growth factors with proven in vitro angiogenic and adipogenic properties.It is obtained by a simple lipoaspirate procedure. We sought to compare the effect of ATE with another known source, platelet-rich plasma to compare the wound healing characteristics on skin graft donor sites.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWound Healing Disturbance of
CountriesFinland
Collaborators--

Timeline

Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 14, 2016
Enrollment StartJun 1, 2015
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 10.0 years ago

Interventions

ADIPOSE TISSUE EXTRACTbiological

Adipose tissue extract is obtained on site with lipoaspirate adipose tissue prepared though incubation and filtration

PLATELET-RICH PLASMA GELbiological

Autologous platelet rich plasma is obtained onsite and activated following commercial kit instructions